Results 21 to 30 of about 31,414 (269)
Cardiac Sarcoidosis (CS) is a deadly consequence of systemic sarcoidosis that inflames all three layers of the heart, especially the myocardium—clinical signs of CS range from asymptomatic disease to abrupt cardiac death. CS generally remains undiagnosed
H. H. Shah +7 more
semanticscholar +1 more source
Background: Sarcoidosis is a systemic inflammatory disorder and can often affect any other organs beyond the heart. Whole-body 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is used to detect not only cardiac but also extra-cardiac ...
Haruhiko Higashi +8 more
doaj +1 more source
Machine-Learning-Based Diagnostics of Cardiac Sarcoidosis Using Multi-Chamber Wall Motion Analyses
Background: Hindered by its unspecific clinical and phenotypical presentation, cardiac sarcoidosis (CS) remains a challenging diagnosis. Objective: Utilizing cardiac magnetic resonance imaging (CMR), we acquired multi-chamber volumetrics and strain ...
Jan Eckstein +10 more
semanticscholar +1 more source
High-risk and low prevalence disease: Cardiac sarcoidosis and some of its mimics
In this narrative review of cardiac sarcoidosis, based on a literature search using the terms “cardiac sarcoidosis”, “tuberculous myocarditis”, “Whipple’s disease and myocarditis”, and”idiopathic giant cell myocarditis”, I have defined cardiac ...
Oscar M.P. Jolobe
doaj +1 more source
Hyperparathyroidism Presenting as Acute Pancreatitis: Case Report of Mortality [PDF]
Background: Acute pancreatitis may be caused by a myriad of factors, hypercalcemia secondary to hyperparathyroidism, albeit is a rare cause of acute pancreatitis but not unheard of.
Gillani, M. M. (Muhammad) +1 more
core +1 more source
Challenges in diagnosing cardiac sarcoidosis: should we increase our index of suspicion?
Sarcoidosis is a multisystem disease involving the lungs in up to 90% of cases; however, 30% of patients will have systemic sarcoidosis, including involvement of the heart. Cardiac sarcoidosis can affect any part of the heart and manifest in various ways,
Ariana Rose Tagliaferri
doaj +1 more source
Background: Tumor necrosis factor (TNF) inhibitors have been used in the treatment of cardiac sarcoidosis, infliximab being the most commonly used.
Jaleel Jerry G. Sweis +14 more
doaj +1 more source
Management of the arrhythmic manifestations of cardiac sarcoidosis
Cardiac sarcoidosis (CS) is characterised by a high burden of arrhythmic manifestations and cardiac electrophysiologists play an important role in both the diagnosis and management of this challenging condition.
Callum Cherrett +3 more
semanticscholar +1 more source
Bidirectional ventricular tachycardia in cardiac sarcoidosis. [PDF]
A 73-year-old man with history of pulmonary sarcoidosis was found to have runs of non-sustained bidirectional ventricular tachycardia (BVT) with two different QRS morphologies on a Holter monitor.
Benjamin, Mina M +4 more
core +2 more sources
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group. [PDF]
Cancer immunotherapy has transformed the treatment of cancer. However, increasing use of immune-based therapies, including the widely used class of agents known as immune checkpoint inhibitors, has exposed a discrete group of immune-related adverse ...
Abdallah, K. +80 more
core +2 more sources

